Exploring the Limits of Ribosome Mediated Polymerizations for Expanding the Genetic Code

探索核糖体介导的聚合对扩展遗传密码的限制

基本信息

  • 批准号:
    10350599
  • 负责人:
  • 金额:
    $ 2.08万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-01-25 至 2022-05-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY Recombinant protein production (RPP) has become a powerful tool for producing life-saving therapeutics such as insulin, monoclonal antibodies, and other critical biopharmaceuticals. However, this promising technology is severely limited by the ability to efficiently expand the genetic code to incorporate exotic monomers and backbones for enhanced therapeutic function. The vast majority of biopolymers currently produced by the translation machinery display polyamide backbones; therefore, the possible secondary and tertiary confirmations available to proteomimetics synthesized via RPP are limited to these scaffolds. Since monomer sequence defines structure and structure defines function, expanding the available monomer pool for translation will produce biopolymers with greater structural complexity and thus increase the functional capabilities for proteomimetic therapeutics. A major limitation to addressing this issue is the underexplored capability of the ribosome to incorporate unnatural monomers, especially those that do not form peptide (amide) bonds. Toward this goal, this proposal aims to develop genetically encoded chemistries that can be catalyzed by the ribosome to synthesize sequence defined polymers (SDPs) with structurally diverse backbones (non-peptide bonds). Specifically, I will design and synthesize a library of a-hydrazino-keto ester monomers, charge them onto orthogonal tRNA, introduce them to the translation machinery in vitro, and evaluate the ability of the ribosome to catalyze their polymerizations. The hydrazine and keto ester moieties are known to react in solution to form various heterocyclic products. Importantly, the last mechanistic step in heterocyclic formation is amide bond formation, a specialty of the ribosome. Therefore, I hypothesize that bifunctional monomers comprised of both these moieties are capable of forming heterocyclic linkages via ribosome mediated catalysis. Encouraging preliminary results by our collaborative and interdisciplinary research team have suggested this goal is achievable as we have found the ribosome to be more accommodating than previously thought. The experiments in this proposal will (1) broaden our understanding of molecular translation, (2) elucidate the limitations and principles that govern genetic code reprogramming, and (3) expand the synthetic toolbox for the development of biologically derived SDPs via the ribosome. Accomplishing the aims in this proposal will increase the backbone diversity currently attainable by the translation machinery and could produce SDPs that might exhibit greater therapeutic efficacy.
项目总结 重组蛋白生产(Rpp)已成为生产救命食品的有力工具。 治疗药物,如胰岛素、单抗和其他关键生物药物。不过,这个 前景看好的技术严重受限于有效扩展遗传密码以整合 异国情调的单体和骨架,增强治疗功能。目前绝大多数生物聚合物 由平移机械制作的显示聚酰胺主干;因此,可能的次要和 通过RPP合成的蛋白质组学可用的三级确认仅限于这些支架。自.以来 单体序列定义结构,结构定义功能,扩展了可用的单体池 翻译将产生结构更复杂的生物聚合物,从而增加功能 蛋白质仿制疗法的能力。解决这个问题的一个主要限制是没有得到充分的探索 核糖体结合非天然单体的能力,尤其是那些不形成多肽的单体 (酰胺)债券。为了实现这一目标,该提案旨在开发基因编码的化学物质, 在核糖体的催化下合成结构多样的序列确定聚合物 骨架(非肽键)。 具体地说,我将设计并合成一个a-肼基酮基酯单体的库,对它们进行充电 在正交tRNA上,将其引入体外翻译机器中,并评估其能力 核糖体催化它们的聚合。已知联氨和酮酯部分在 形成各种杂环产品的溶液。重要的是,杂环形成的最后一个机械步骤是 酰胺键形成,核糖体的一种特长。因此,我假设双官能团单体 由这两个部分组成的分子能够通过核糖体介导形成杂环连接 催化作用。我们的协作和跨学科研究团队取得了令人鼓舞的初步成果 暗示这一目标是可以实现的,因为我们发现核糖体比以前更容易适应 想着。这个方案中的实验将(1)扩大我们对分子翻译的理解,(2) 阐明管理遗传密码重新编程的限制和原则,以及(3)扩展合成的 通过核糖体开发生物衍生SDPs的工具箱。实现这一目标 提议将增加翻译机构目前可实现的骨干多样性,并可能 生产可能表现出更大治疗效果的SDP。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Ribosome-mediated biosynthesis of pyridazinone oligomers in vitro.
  • DOI:
    10.1038/s41467-022-33701-2
  • 发表时间:
    2022-10-24
  • 期刊:
  • 影响因子:
    16.6
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jaime N Coronado其他文献

Jaime N Coronado的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 2.08万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.08万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 2.08万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.08万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 2.08万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.08万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 2.08万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 2.08万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 2.08万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.08万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了